Author(s) :

Minahil Irshad, Umema Sehrish, Noor Fatima, Amna Naveed , Fatima Qamar.

Volume/Issue :

Abstract :

The prevalence of autoimmune diseases is rising globally, and they are still challenging to treat because immunological dysregulation and the limitations of traditional treatments. Probiotics have shown potential as immunomodulators that can affect host immunity in a number of ways, such as regulating T-cells, increasing mucosal IgA secretion, and modifying cytokines response. Their potential to lower inflammation and restore immunological tolerance is suggested by early clinical research. The productivity of probiotics differs greatly depending on the strain and is impacted by host characteristics like food, microbiome composition, and genetics. Their the therapeutic usage is still limited by issues like inconsistent clinical results, a lack of standardization, and a lack of safety data. Next-generation strains, tailored probiotics, and integration with multi-omics techniques are the main area of research for future research. Probiotics are useful supplement in the developing of treatment autoimmune disease.

No. of Downloads :

0